Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
Clinical trial NCT06205056 · RECRUITING
Trial details
- NCT number
- NCT06205056
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-30
- Primary completion
- 2025-12-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.